Bioprocess Validation Market Size to Cross USD 1,179.55 Million by 2034
HealthcareThe global bioprocess validation market, valued at USD 537.30 million in 2025, is poised for robust expansion, forecasted to nearly double to USD 1,179.55 million by 2034 with a CAGR of 9.13%. This growth is underpinned by the surge in biopharmaceutical manufacturing, especially cell and gene therapies, combined with increasing regulatory requirements and the adoption […]